We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to request and manage school-led initial teacher training (ITT) places for School Direct.
Guidance for the pharmaceutical industry on how to apply to vary a veterinary Marketing Authorisation (MA) or Homeopathic Remedy.
Guidance on Conditional Marketing Authorisations, exceptional circumstances Marketing Authorisations and national scientific advice
How to use a multiphase optimisation strategy (MOST) to evaluate your digital health product.
An overview of the process including submitting or fast tracking an application, naming your medicine and paying fees.
Guidance for the pharmaceutical industry on who can be a Marketing Authorisation Holder, named distributor or local representative and how to make changes to these.
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
Business plans - download free templates and get help writing a business plan
This guidance outlines how to create and implement a cloud strategy, and when to consider a single, hybrid or multi-cloud solution.
How the MHRA processes variations to Marketing Authorisations (MAs)
How to make sure that your products are properly checked for conformity and your technical documents are managed correctly.
This strategy sets out our vision of the role of the retail market in achieving net zero.
Find out if your business needs to publish a tax strategy, what it should include and when to publish it.
Use the rolling review route when you want to submit your eCTD dossier in separate parts for pre-assessment instead of making a full consolidated document submission.
From 13 May 2024 we are introducing a change to the procedure for new Marketing Authorisation (MA) applications, where a joint assessment of labels is requested.
How to apply for marketing authorisation via this new procedure.
Details of the process changes for established medicines, effective from 1 March 2024, which apply specifically to chemical products.
Understand and avoid all types of anti-competitive and cartel activity including price-fixing, collusion, bid-ridding and sharing markets. Know how to report concerns to the CMA.
How the MHRA assesses Marketing Authorisation Applications (MAA) for medicines referred under Article 29.
Guidance for holders of Marketing Authorisations approved in Northern Ireland or the EU/EEA member states who want to bring a product to market in Great Britain.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.